|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 47/26 | |||
| A61K 9/08 | |||
| C07K 16/22 | |||
| C07K 16/28 |
| (11) | Number of the document | 2968553 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14772646.7 |
| Date of filing the European patent application | 2014-03-13 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/026824 |
| Date | 2014-03-13 |
| (87) | Number | WO 2014/160490 |
| Date | 2014-10-02 |
| (30) | Number | Date | Country code |
| 201361780899 P | 2013-03-13 | US |
| (72) |
GOKARN, Yatin, US
ZARRAGA, Isidro, E., US
ZARZAR, Jonathan, US
PATAPOFF, Thomas, US
WURTH, Christine, CH
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | ANTIBODY FORMULATIONS |
| ANTIBODY FORMULATIONS |